Eleuthero (Eleutherococcus senticosus), also called Siberian ginseng, was the adaptogen that launched the field. Soviet pharmacologist Nikolai Lazarev coined the term "adaptogen" in 1947, and his colleague Israel Brekhman spent decades researching eleuthero in particular — working with the Soviet military, Olympic athletes, and cosmonauts to understand its effects on physical and mental performance under stress.

Eleutherosides: Different from Ginsenosides

Eleuthero is unrelated to Panax ginseng despite the common name "Siberian ginseng." Its active compounds are eleutherosides — a different class of molecules entirely. Eleutherosides appear to influence adrenal function, immune activity, and cardiovascular response to stress. The mechanism is less well characterised than ashwagandha's withanolides, which is partly why eleuthero has fallen somewhat out of favour in research relative to newer adaptogens.

Key Facts

What the Research Found

The Soviet research base — though methodologically dated by modern standards — consistently found improvements in endurance, immune function, and recovery from physical stress. More recent studies have found modest improvements in cardiovascular efficiency during exercise and reductions in post-exercise cortisol. It appears to be genuinely useful for people whose primary stressor is physical rather than cognitive.

Eleuthero's legacy is worth acknowledging: it directly led to the systematic study of adaptogens as a class. The compounds discovered later — rhodiola's rosavins, ashwagandha's withanolides — were found partly because researchers were looking for what made eleuthero work.

Where It Fits Today

Eleuthero is more commonly found in combination formulas than as a standalone supplement these days. At meaningful doses in a well-formulated blend, it adds an endurance and immune-support dimension that more cognitively-focused adaptogens don't cover. For athletes or physically active people, it remains a relevant choice.